Evaluation of intervention strategies to manage fatigue during active treatment and to prevent persistent fatigue after curative treatment for cancer
- Conditions
- Cancer, curative treatment, fatigueCancerFatigue in cancer patients
- Registration Number
- ISRCTN20583070
- Lead Sponsor
- niversity Medical Centre St. Radboud (The Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 300
1. Patients just have been diagnosed for breast cancer, colorectal cancer, cervix cancer, uterus cancer, testis cancer, Hodgkin and non-Hodgkin disease
2. Patients in preparation of receiving therapy with curative intention (chemotherapy, radiotherapy and/or surgery)
3. 18 to 70 years old
4. Patients must be able to speak and write Dutch and to fill out the questionnaires independently
5. Patients have no somatic co-morbidity unrelated to the malignancy, that can co-exist with fatigue
Does not comply with the above inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue severity will be measured using the Checklist Individual Strength. The Checklist Individual Strength is a 20-item questionnaire, designed to measure four aspects of fatigue over the last 14 days, namely: <br>1. Fatigue severity (eight items)<br>2. Concentration (five items)<br>3. Motivation (four items)<br>4. Physical activity (three items)<br><br>Each item is scored on a seven-point Likert scale. High scores indicate a high level of fatigue, a high level of concentration problems, low motivation and a low level of activity. Psychometric properties are excellent. A score of 35 or higher on the subscale fatigue severity indicates severe feelings of fatigue. Norm scores of different patients groups and healthy controls are available.
- Secondary Outcome Measures
Name Time Method